Actively Recruiting

Age: 18Years +
All Genders
NCT06973239

Evaluation of the Safety and Performance of the Neocement® Inject P

Led by Bioceramed · Updated on 2026-02-04

80

Participants Needed

1

Research Sites

90 weeks

Total Duration

On this page

Sponsors

B

Bioceramed

Lead Sponsor

L

Local Health Unit Barcelos/Esposende, Public Health Unit

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study aims to collect real-world clinical data to gather information on the performance and safety of the Neocement® Inject P when used according to its intended purpose and current clinical applications. The results of the clinical study will serve as clinical evidence for the device's clinical evaluation, targeting submission to the new Medical Device Regulation (EU) 2017/745.

CONDITIONS

Official Title

Evaluation of the Safety and Performance of the Neocement® Inject P

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult males or females (age > 18 years old);
  • Patients with bone defect treatment who meet predefined criteria in Instructions For Use (IFU) of Neocement® Inject P;
  • Patients who are able to sign an informed consent form (for data collection)
  • Patients with bone defects, which may be surgically created or result from traumatic injury to the bone;
  • Patients with bone skeletal defects that are not intrinsic to the stability of the bone structure or with a site that can be stabilized;
Not Eligible

You will not qualify if you...

  • Patients who are unable to understand consent and the objectives of the study;
  • Signs of local or systemic acute/ active or chronic infections;
  • Metabolic affections;
  • Severe degenerative diseases, conditions in which general bone grafting is not advisable;
  • Implementation sites that allow product migration;
  • Conditions which require structural support in the skeletal system;
  • Conditions where the implantation site is unstable and not rigidly fixated;
  • Sensibility to the implantable materials;
  • Known hypersensitivity to the implant material.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Unidade Local de Saúde Esposende/Barcelos

Barcelos, Portugal

Actively Recruiting

Loading map...

Research Team

A

Alexandre Barros

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here